ANDERA PARTNERS

Position in EVMN — Evommune, Inc.

CIK 1757283 PARIS, I0

Position in EVMN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$43,620,352

+$11,137,515 QoQ

Shares Held

1,897,362

0.0% QoQ

Ownership

5.27%

of shares outstanding

% of Portfolio

24.66%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ANDERA PARTNERS holds $121,676,488 across 5 Biotechnology names. EVMN ranks #1 (35.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc. This page	1,897,362	$43,620,352
2	MLYS	Mineralys Therapeutics, Inc.	1,591,917	$43,125,031
3	AGMB	Agomab Therapeutics NV	1,538,702	$16,140,983
4	IVA	Inventiva S.A.	1,818,181	$10,090,904
5	ABVX	Abivax S.A.	78,125	$8,699,218

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,620,352	1,897,362	0.0%	Shares	Sole	2026-05-11
2025-12-31	$32,482,837	1,897,362	0.0%	Shares	Sole	2026-02-17
2025-11-07	$34,930,434	1,897,362	—	Shares	Sole	2025-11-17
No filing history on record for this holder in this stock.